Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115637) titled 'Clinical study of dapagliflozin in Patients with diabetes mellitus complicated with peripheral neuropathy - A randomized controlled study' on Dec. 29, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Nanjing Integrated Traditional Chinese and Western Medicine Hospital Affiliated with Nanjing University of Chinese Medicine
Condition:
diabetes
Intervention:
treatment group:Take Dapagliflozin tablets.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: treatment group:42;control group:42;
Countries of Recruitment:
China...